Scientists at Washington University School of Medicine identified a blood protein fragment, eMTBR-tau243, that is elevated in people with advanced chronic traumatic encephalopathy (CTE). Currently, CTE can only be diagnosed post-mortem, but this biomarker opens the possibility of living diagnosis, t